TCL Archive The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff. October 21, 2005
TCL Archive “Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.” July 14, 1995
TCL Archive NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial May 14, 2010
